Chardan Capital Reiterates “Buy” Rating for Ocugen (NASDAQ:OCGN)
Ocugen (NASDAQ:OCGN – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Chardan Capital in a research note issued on Monday,Benzinga reports. They currently have a $6.00 price objective on the stock. Other research analysts also recently issued research reports about the company. Maxim Group assumed coverage on Ocugen in a […]
More Stories
AECOM (NYSE:ACM) Releases FY 2025 Earnings Guidance
AECOM (NYSE:ACM – Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The company...
Fathom Holdings Inc. (NASDAQ:FTHM) Director Stephen H. Murray Purchases 20,000 Shares
Fathom Holdings Inc. (NASDAQ:FTHM – Get Free Report) Director Stephen H. Murray acquired 20,000 shares of the company’s stock in...
New Horizon Aircraft Ltd. (NASDAQ:HOVR) Short Interest Update
New Horizon Aircraft Ltd. (NASDAQ:HOVR – Get Free Report) was the recipient of a large drop in short interest in...
Short Interest in Brinker International, Inc. (NYSE:EAT) Decreases By 8.1%
Brinker International, Inc. (NYSE:EAT – Get Free Report) saw a significant decline in short interest during the month of October....
Contrasting Barnwell Industries (NYSE:BRN) and Royale Energy (OTCMKTS:ROYL)
Volatility and Risk Barnwell Industries has a beta of 0.14, indicating that its stock price is 86% less volatile than...
Credicorp Ltd. (NYSE:BAP) Short Interest Update
Credicorp Ltd. (NYSE:BAP – Get Free Report) was the recipient of a large drop in short interest during the month...